Product Information
GATIFLOXACIN 0.5% EYE DROPS is a generic product labeled by Pacific Pharma, Inc., priced at $12.0110 per ML under NDC 60758061525. Its NADAC has been published 489 times since Jul 8, 2015.
FDA first approved this application on May 18, 2010. Its Orange Book therapeutic-equivalence code is AT.
Strength
5 mg/mL
Manufacturer
Pacific Pharma, Inc.NDC
60758061525
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
10/23/2024
Active Ingredients
GATIFLOXACINApproval Type
Authorized Generic (NDA)
FDA Application
NDA022548FDA Approved
5/18/2010
TE Code
AT
On Market Since
4/15/2015
Pharmacological Classes
Price Statistics
The NADAC for GATIFLOXACIN 0.5% EYE DROPS has been published 489 times since Jul 8, 2015, and over the history we have for it it has declined 70.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.0110 per ML |
|---|---|
| All-time high | $40.5267 (Jul 15, 2015) |
| All-time low | $7.7238 (Apr 17, 2024) |
| Median price | $17.0494 |
| Average price | $19.9634 |
| Largest weekly change | +56.3% (Feb 17, 2021) |
| Weeks tracked | 489 |
| Tracking since | Jul 8, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+3.5%
5Y
-11.8%
All
-70.4%
Last surveyed Nov 13, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Pacific Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
gatifloxacin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Quinolone Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GATIFLOXACIN 0.5% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for GATIFLOXACIN 0.5% EYE DROPS, manufactured by Pacific Pharma, Inc., is $12.0110 per ML (NDC 60758061525), effective Nov 13, 2024.
How has the price of GATIFLOXACIN 0.5% EYE DROPS changed over time?
Over the history we have for it, the NADAC for GATIFLOXACIN 0.5% EYE DROPS has declined 70.4%. It has been tracked across 489 weekly CMS publications since Jul 8, 2015.
What are the highest and lowest recorded NADAC prices for GATIFLOXACIN 0.5% EYE DROPS?
Since Jul 8, 2015, the NADAC for GATIFLOXACIN 0.5% EYE DROPS has ranged from a low of $7.7238 (Apr 17, 2024) to a high of $40.5267 (Jul 15, 2015), with a median of $17.0494 per ML.
Are there cheaper alternatives to GATIFLOXACIN 0.5% EYE DROPS?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GATIFLOXACIN 0.5% EYE DROPS, is $8.8549 per ML — about 26% below GATIFLOXACIN 0.5% EYE DROPS.
Who manufactures GATIFLOXACIN 0.5% EYE DROPS?
GATIFLOXACIN 0.5% EYE DROPS (NDC 60758061525) is labeled by Pacific Pharma, Inc., and CMS classifies it as a generic product.